Latest Breaking News On - Blue earth therapeutics - Page 3 : comparemela.com

Blue Earth Diagnostics Highlights Clinical Utility of POSLUMA® (Flotufolastat F 18) PET and Post-scan Changes in Management in Patients with Suspected Recurrence of Prostate Cancer at ASCO GU

Blue Earth Diagnostics Highlights Clinical Utility of POSLUMA® (Flotufolastat F 18) PET and Post-scan Changes in Management in Patients with Suspected Recurrence of Prostate Cancer at ASCO GU
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

Santa monicaScintomics gmbPrzemyslaw twardowskiDavide gaudenStudy groupDrug administrationBlue earth diagnostics ltdTechnical university of munichProduct serviceA siemens healthineers companySolutions incBracco groupNuclear medicineTrade showEarth diagnostics highlights clinical utilityPost scan changes

Blue Earth Diagnostics Ltd Collaborates with Sinotau Pharmaceutical Group to Bring Prostate Cancer PET Diagnostic Imaging Agent, Flotufolastat (18F) Injection, to China

Blue Earth Diagnostics Ltd Collaborates with Sinotau Pharmaceutical Group to Bring Prostate Cancer PET Diagnostic Imaging Agent, Flotufolastat (18F) Injection, to China
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomIhre chancenPriscilla harlanClare gidleyMatt morrisonDavide gaudenYanmin tangScintomics gmbIndiens wirtschaftMike beyerChinese society of clinical oncologyNuclear medicineTechnical university of munichSinotau pharmaceutical groupCorporate communications

Blue Earth Diagnostics Ltd Collaborates with Sinotau Pharmaceutical Group to Bring Prostate Cancer P

− Agreement with Sinotau Pharmaceutical Group part of Company’s global strategy to increase clinician and patient access to innovative diagnostic imaging agent –OXFORD, England & MONROE TOWNSHIP, N.J. (BUSINESS WIRE) Blue Earth Diagnostics Ltd, a Bracco company and recognised leader in the development and commerci.

United kingdomUnited statesDavide gaudenClare gidleyMike beyerYanmin tangPriscilla harlanMatt morrisonScintomics gmbChinese society of clinical oncologyBracco groupNuclear medicineBlue earth diagnostics ltdSam brown incSinotau pharmaceutical groupCorporate communications

New Data on POSLUMA® (Flotufolastat F 18) in Patients with Suspected Biochemical Recurrence of Prostate Cancer and Low-Very Low Prostate Specific Antigen (PSA) Levels Presented at ASTRO

New Data on POSLUMA® (Flotufolastat F 18) in Patients with Suspected Biochemical Recurrence of Prostate Cancer and Low-Very Low Prostate Specific Antigen (PSA) Levels Presented at ASTRO
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomClare gidleyMike beyerDavide gaudenScintomics gmbAsheshb janiPriscilla harlanSam brown incStudy groupCorporate communicationsNuclear medicineWinship cancer institute of emory universitySolutions incBracco groupTechnical university of munichA siemens healthineers company

New Data on POSLUMA® (Flotufolastat F 18) in Patients with Suspected Biochemical Recurrence of Prost

− Post-hoc analysis from Blue Earth Diagnostics’ Phase 3 SPOTLIGHT trial provides data about treatment planning, particularly when curative salvage therapy is considered –For U.S audiences onlyMONROE TOWNSHIP, N.J. & OXFORD, England (BUSINESS WIRE) Blue Earth Diagnostics, a Bracco company and recognized leader in.

United kingdomScintomics gmbClare gidleyPriscilla harlanAsheshb janiMike beyerStudy groupSam brown incDrug administrationBracco groupTechnical university of munichNuclear medicineWinship cancer institute of emory universityCorporate communicationsBlue earth diagnostic phaseBlue earth diagnostics